文献速递神经介入DSA

EmboTrap II支架取栓器机械取栓的早期上市后多中心结果

Early Postmarket Results with EmboTrap II Stent Retriever for Mechanical Thrombectomy: A Multicenter Experience.
PubMed 文献 · AJNR Am J Neuroradiol · 2021-03-11

作者认为早期上市后结果良好,与其他商用支架取栓器相当,但首过有效率可能低于第一代EmboTrap,数据受回顾性病例分析、临床随访不完整和样本量小限制。

要点

  • EmboTrap II取栓TICI≥2b再通率95.7%,仅用该器械病例为82.3%。
  • 首过有效率为35.7%,平均每例2.5次[SD,1.8]取栓尝试(含非EmboTrap尝试)。
  • 无器械相关并发症,症状性出血转化占4.3%。

关键影像表现/征象

  • 闭塞部位:ICA 18例,M1 38例,M2或M3 13例,基底动脉1例。
  • 88%病例使用5×33 mm器械。
  • 部分出血转化占22.9%,其中症状性占4.3%。
  • 无器械相关并发症。

诊断标准与关键数值

  • TICI≥2b再通率95.7%,仅用EmboTrap II病例为82.3%。
  • 首过有效率为35.7%。
  • 平均每例取栓尝试2.5次[SD,1.8],含非EmboTrap尝试。
  • 9例(12.9%)使用替代器械(抽吸或支架取栓器)完成确定性治疗。

临床应用与阅片要点

  • EmboTrap II可用于急性大血管闭塞机械取栓,TICI≥2b再通率与现有支架取栓器相当。
  • 仅用EmboTrap II时TICI≥2b再通率为82.3%,部分病例需替代器械完成治疗。
  • 首过有效率为35.7%,第一代EmboTrap可能更高,但证据受限。

局限性

  • 数据受回顾性病例分析限制。
  • 临床随访不完整。
  • 样本量小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: EmboTrap II is a novel stent retriever with a dual-layer design and distal mesh designed for acute ischemic stroke emergent large-vessel occlusions. We present the first postmarket prospective multicenter experience with the EmboTrap II stent retriever.

MATERIALS AND METHODS: A prospective registry of patients treated with EmboTrap II at 7 centers following FDA approval was maintained with baseline patient characteristics, treatment details, and clinical/radiographic follow-up.

RESULTS: Seventy patients were treated with EmboTrap II (mean age, 69.9 years; 48.6% women). Intravenous thrombolysis was given in 34.3%, and emergent large-vessel occlusions were located in the ICA (n = 18), M1 (n = 38), M2 or M3 (n = 13), and basilar artery (n = 1). The 5 × 33 mm device was used in 88% of cases. TICI ≥ 2b recanalization was achieved in 95.7% (82.3% in EmboTrap II-only cases), and first-pass efficacy was achieved in 35.7%. The NIHSS score improved from a preoperative average of 16.3 to 12.1 postprocedure and to 10.5 at discharge. An average of 2.5 [SD, 1.8] passes was recorded per treatment, including non-EmboTrap attempts. Definitive treatment was performed with an alternative device (aspiration or stent retriever) in 9 cases (12.9%). Some hemorrhagic conversion was noted in 22.9% of cases, of which 4.3% were symptomatic. There were no device-related complications.

CONCLUSIONS: Initial postmarket results with the EmboTrap II stent retriever are favorable and comparable with those of other commercially available stent retrievers. Compared with EmboTrap II, the first-generation EmboTrap may have a higher first-pass efficacy; however, data are limited by retrospective case analysis, incomplete clinical follow-up, and small sample size, necessitating future trials.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Srivatsan A, Srinivasan VM, Starke RM, et al. Early Postmarket Results with EmboTrap II Stent Retriever for Mechanical Thrombectomy: A Multicenter Experience. AJNR Am J Neuroradiol. 2021. PMID: 33707283. doi:10.3174/ajnr.A7067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。